Celularity Inc. Operating Lease, Payments
Celularity Inc. (CELU) reported Operating Lease, Payments of $3.45 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-04-30
- Celularity Inc. operating lease, payments for the quarter ending 2025-12-31 was $863.00K, a 2.25% increase year-over-year.
- Celularity Inc. operating lease, payments for the quarter ending 2025-09-30 was $863.00K, a 2.13% increase year-over-year.
- Celularity Inc. operating lease, payments for the quarter ending 2025-06-30 was $863.00K, a 2.25% increase year-over-year.
- Celularity Inc. operating lease, payments for the quarter ending 2025-03-31 was $863.00K, a 2.13% increase year-over-year.
- Celularity Inc. operating lease, payments for fiscal 2025 was $3.45M, a 2.19% increase from fiscal 2024.
- Celularity Inc. operating lease, payments for fiscal 2024 was $3.38M, a 112687.98% increase from fiscal 2023.
- Celularity Inc. operating lease, payments for fiscal 2023 was $3.00K, a 99.89% decline from fiscal 2022.
- Celularity Inc. operating lease, payments for fiscal 2022 was $2.83M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $863.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $1.73M derived: sum of 2 quarters · filed 2026-04-30 | $2.59M derived: sum of 3 quarters · filed 2026-04-30 | $3.45M 10-K · filed 2026-04-30 | |
| 2025-09-30 | $863.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.73M derived: sum of 2 quarters · filed 2025-11-14 | $2.59M 10-Q · filed 2025-11-14 | $3.43M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2025-06-30 | $863.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-29 | $1.73M 10-Q · filed 2025-08-29 | $2.57M derived: sum of 3 quarters · filed 2026-04-30 | $3.42M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2025-03-31 | $863.00K 10-Q · filed 2025-08-29 | $1.71M derived: sum of 2 quarters · filed 2026-04-30 | $2.55M derived: sum of 3 quarters · filed 2026-04-30 | $3.40M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2024-12-31 | $844.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $1.69M derived: sum of 2 quarters · filed 2026-04-30 | $2.53M derived: sum of 3 quarters · filed 2026-04-30 | $3.38M 10-K · filed 2026-04-30 | $3.38K 10-K · filed 2025-05-08 |
| 2024-09-30 | $845.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.69M derived: sum of 2 quarters · filed 2025-11-14 | $2.53M 10-Q · filed 2025-11-14 | $369.00K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $844.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-29 | $1.69M 10-Q · filed 2025-08-29 | -$476.00K derived: sum of 3 quarters · filed 2025-08-29 | $251.00K derived: sum of 4 quarters · filed 2025-08-29 | |
| 2024-03-31 | $845.00K 10-Q · filed 2025-08-29 | -$1.32M derived: sum of 2 quarters · filed 2025-08-29 | -$593.00K derived: sum of 3 quarters · filed 2025-08-29 | $133.00K derived: sum of 4 quarters · filed 2025-08-29 | |
| 2023-12-31 | -$2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-08 | -$1.44M derived: sum of 2 quarters · filed 2025-05-08 | -$712.00K derived: sum of 3 quarters · filed 2025-05-08 | $3.00K 10-K · filed 2025-05-08 | $3.00M 10-K · filed 2024-07-30 |
| 2023-09-30 | $727.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-06 | $1.45M derived: sum of 2 quarters · filed 2024-12-06 | $2.17M 10-Q · filed 2024-12-06 | $2.88M derived: sum of 4 quarters · filed 2024-12-06 | |
| 2023-06-30 | $726.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $1.44M 10-Q · filed 2024-11-07 | $2.15M derived: sum of 3 quarters · filed 2024-11-07 | $2.86M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-03-31 | $715.00K 10-Q · filed 2024-10-16 | $1.42M derived: sum of 2 quarters · filed 2024-10-16 | $2.13M derived: sum of 3 quarters · filed 2024-10-16 | $2.84M derived: sum of 4 quarters · filed 2024-10-16 | |
| 2022-12-31 | $709.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $1.42M derived: sum of 2 quarters · filed 2024-07-30 | $2.13M derived: sum of 3 quarters · filed 2024-07-30 | $2.83M 10-K · filed 2024-07-30 | |
| 2022-09-30 | $708.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-03 | $1.42M derived: sum of 2 quarters · filed 2024-01-03 | $2.13M 10-Q · filed 2024-01-03 | ||
| 2022-06-30 | $709.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.42M 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $708.00K 10-Q · filed 2023-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |